Revenue

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

As AI fakes threaten truth, Reality Defender recruits pioneers from Google, Twitter, and academia to build an ethical framework for detection technology.

With new COO Sarah Campbell and fresh capital, Future Technologies is scaling aggressively to solve the critical 'AI Connectivity Gap' for major industries.

Backed by Mastercard, Visa, and top VCs, Astrada is building the real-time data infrastructure for the coming age of AI-managed enterprise finance.

A first-of-its-kind P&C product aims to protect small medical practices from unique financial risks, launched in record time on an agile insurtech platform.

A novel gene therapy aims to cross the blood-brain barrier, offering new hope for Tuberous Sclerosis Complex, thanks to a powerful new partnership.

The Grammy-winning bassist and vocalist brings a unique, intimate quartet experience to the W Hollywood for an exclusive, one-night performance.

A new biotech emerges with a promising, late-stage gene therapy for Sanfilippo syndrome, offering a potential lifeline for children with no other options.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

As SAP’s 2027 ECC support deadline looms, firms face a tough choice. New services offer a third way beyond the vendor's roadmap.

Recognized by Avasant, YASH Technologies is reshaping infrastructure management with predictive AI, automation, and key partnerships. Here's what it means.

The iconic vertical destination unveils its Tower Club Signature Collection, blending hyper-exclusive suites with Michelin-starred dining and Thai elegance.

This Vision Health Month, learn why your eyes need more than a simple check-up and how a surgeon's specialized medical expertise is key to preventing vision loss.

Shopify crushes Q1 with 34% revenue growth and $100B in merchant sales, yet its stock falters on a cautious outlook. Is its AI bet enough to win investors?

Broker-dealer AmerX launches an equity research division, integrating its NYSE floor presence with a new focus on physical AI to deliver actionable insights.

Atkore's Q2 revenue rose 4.2%, but a $136.5M antitrust settlement drove a major net loss. The company divests assets to focus on its electrical core.

Operational failures at a key new mine pushed Peabody to a Q1 loss, overshadowing strong thermal coal profits fueled by geopolitical conflict.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

The utility giant posted strong first-quarter earnings, driven by surging industrial demand, and reaffirmed its outlook amid a historic investment plan.